Posterior reversible encephalopathy syndrome in a child with Guillian-Barre syndrome

被引:0
作者
Phulwani, Nirmal K. [1 ,2 ]
Khatri, Jyoti [3 ]
Ramakrishnaiah, Raghu H. [1 ,2 ]
Shah, Chetan C. [1 ,2 ]
机构
[1] Univ Arkansas Med Sci, Dept Radiol, Little Rock, AR USA
[2] Arkansas Childrens Hosp, Dept Pediat Neuroradiol, Little Rock, AR 72202 USA
[3] Conway Reg Med Ctr, Dept Internal Med, Little Rock, AR USA
关键词
PRES; GBS; hypertension; autonomic dysfunction; edema; infection;
D O I
暂无
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Posterior reversible encephalopathy syndrome (PRES) (synonym: reversible posterior leukoencephalopathy syndrome, reversible posterior cerebral edema syndrome) is a neurotoxic state associated with sudden elevation in blood pressure. It presents initially with lethargy and somnolence but can also manifest as headache, confusion, hemianopsia, nausea vomiting, seizures, vision disturbance, paresis, and cortical blindness. Very often these features are short lived and are resolved both clinically and radiologically but occasionally this disease can progress to coma and other devastating permanent complications. Several etiological factors have been described in literature including hypertensive encephalopathy, preeclampsia, eclampsia, infection, immunosuppression, autoimmune diseases, cyclosporine toxicity, drug overdose, trauma with aortic dissection, pheochromocytoma and Guillain-Barre syndrome (GBS). Particularly, very few cases have been reported in literature indicating GBS as a precipitating factor for PRES. Therefore, we present here a brief review of literature describing association between GBS and PRES along with detailed diagnostic and therapeutic description. This review suggests necessity for adequate clinical suspicion for PRES in GBS afflicted patient followed by prompt diagnostic and therapeutic intervention. Failure to treat promptly and adequately might lead to the catastrophic consequence both in terms of morbidity and mortality.
引用
收藏
页码:137 / 141
页数:5
相关论文
共 14 条
[1]   Posterior reversible encephalopathy syndrome, part 1: Fundamental imaging and clinical features [J].
Bartynski, W. S. .
AMERICAN JOURNAL OF NEURORADIOLOGY, 2008, 29 (06) :1036-1042
[2]   Posterior reversible encephalopathy syndrome, part 2: Controversies surrounding pathophysiology of vasogenic edema [J].
Bartynski, W. S. .
AMERICAN JOURNAL OF NEURORADIOLOGY, 2008, 29 (06) :1043-1049
[3]   Neuropathologic findings in a Guillain-Barre patient with strokes after IVIg therapy [J].
Byrne, NP ;
Henry, JC ;
Herrmann, DN ;
Abdelhalim, AN ;
Shrier, DA ;
Francis, CW ;
Powers, JM .
NEUROLOGY, 2002, 59 (03) :458-461
[4]  
Casey SO, 2000, AM J NEURORADIOL, V21, P1199
[5]   Acute, severe self-limiting dysautonomia and hypertensive encephalopathy [J].
Dixon, SF ;
Appleton, RE ;
Davidson, JE ;
Hughes, DA ;
Tedman, BM .
PEDIATRIC NEUROLOGY, 2001, 25 (04) :319-324
[6]   One Thing Leads to Another: GBS Complicated by PRES and Takotsubo Cardiomyopathy [J].
Fugate, Jennifer E. ;
Wijdicks, Eelco F. ;
Kumar, Gautam ;
Rabinstein, Alejandro A. .
NEUROCRITICAL CARE, 2009, 11 (03) :395-397
[7]   Rotavirus infections and vaccines: Burden of illness and potential impact of vaccination [J].
Grimwood K. ;
Lambert S.B. ;
Milne R.J. .
Pediatric Drugs, 2010, 12 (4) :235-256
[8]   A reversible posterior leukoencephalopathy syndrome [J].
Hinchey, J ;
Chaves, C ;
Appignani, B ;
Breen, J ;
Pao, L ;
Wang, A ;
Pessin, MS ;
Lamy, C ;
Mas, JL ;
Caplan, LR .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (08) :494-500
[9]  
Israeli E, 2010, CLIN REV AL IN PRESS
[10]   Guillain-Barre syndrome - Epidemiology, pathophysiology and management [J].
Kuwabara, S .
DRUGS, 2004, 64 (06) :597-610